# Combination Chemotherapy in Treating Patients With Advanced Cancer

> **NCT00024323** · PHASE1 · COMPLETED · sponsor: **Vion Pharmaceuticals**

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** cisplatin
- **DRUG:** triapine

## Key facts

- **NCT ID:** NCT00024323
- **Lead sponsor:** Vion Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-03
- **Primary completion:** —
- **Final completion:** 2003-06
- **Target enrollment:** — (—)
- **Last updated:** 2013-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00024323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00024323, "Combination Chemotherapy in Treating Patients With Advanced Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00024323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*